Clinical Trial Update: Clinical Trial of Rasagiline in Levodopa-Treated Parkinson's Disease Patients With Motor Fluctuations [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating rasagiline added to levodopa in Parkinson's disease with motor fluctuations has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• RASAGILINE (rasagiline)

Snippet

Sponsor: Chongqing Fortune Pharmaceutical Co., Ltd. | Conditions: Parkinson´s Disease | Phase 3 | Status: COMPLETED